Olga Issakova
Chief Operating Officer Tailor Therapeutics
Seminars
Wednesday 22nd July 2026
Navigating Next-Generation Chelators to Differentiate & Advance Radiotherapeutics
1:30 pm
- Presenting targeted radiopharmaceuticals discovery platform designed for a wide range of targets; outlining the importance of chelator choice to achieve optimal stability, specific activity, and pharmacokinetics.
- Showcasing data for novel bifunctional “tunable” chelators superior to DOTA and Macropa
- Introducing advanced methodologies for in-depth preclinical characterization of radiopharmaceuticals using HPLC- ICP/MS techniques
